ask="N/A"
ask_size="N/A"
average_daily_volume="1885170"
bid="N/A"
bid_size="N/A"
book_value="-0.151"
change="+0.002"
change_from_200_day_moving_average="-0.129"
change_from_50_day_moving_average="0.016"
change_from_52_week_high="-0.603"
change_From_52_week_low="0.157"
change_in_percent="+0.409%"
close="0.417"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.464"
ebitda="-30.10M"
eps_estimate_current_year="-0.380"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.320"
ex_dividend_date="N/A"
float_shares="71869000"
high="0.447"
high_52_weeks="1.020"
last_trade_date="1/4/2017"
last_trade_price="0.417"
last_trade_size="100"
last_trade_time="4:01pm"
low="0.417"
low_52_weeks="0.260"
market_capitalization="41.63M"
moving_average_200_day="0.546"
moving_average_50_day="0.401"
name="Protalix BioTherapeutics
Inc. "
notes="N/A"
one_year_target_price="2.400"
open="0.431"
pe_ratio="0.899"
peg_ratio="-0.050"
percent_change_from_200_day_moving_average="-23.686%"
percent_change_from_50_day_moving_average="+4.014%"
percent_change_from_52_week_high="-59.118%"
percent_change_from_52_week_low="+60.385%"
previous_close="0.415"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="5.824"
revenue="7.12M"
shares_outstanding="99821000"
short_ratio="0.100"
stock_exchange="ASE"
symbol="PLX"
volume="2075878"
weeks_range_52="0.260 - 1.020"
